Performance measurement has always only been seen from a financial perspective by all companies, including hospitals. The Balanced Scorecard (BSC) concept approach is an alternative in measuring performance. In addition to considering financial factors but also considering non-financial factors with four perspectives, namely customers, learning, and growth, internal business and finance itself, which are expected to provide a comprehensive assessment to management. The aim is to examine the application of the BSC in hospitals in various countries and assess the feasibility of its application to hospitals in Indonesia. The Method in this study uses a systematic review method, namely by studying investigative articles related to Hospital BSC published in ProQuest, EBSCO, SpringerLink, ScienceDirect and Scopus. Then, outside of UI access, article searches are also done through Google Scholar and apart from getting articles in Indonesian through Garuda. research and technology. The results of this study found that the benefits of implementing BSC in hospitals include increasing focus in the management process, balancing financial and non-financial performance, helping align goals, fostering a positive work culture and increasing work motivation, and encouraging changes in the work environment according to hospital needs. . This study also found that the main challenge in implementing the BSC in hospitals is the required adoption and implementation process. For hospitals in Indonesia, the BSC should be adopted and implemented gradually on a wider scale. Conclusion: This indicates that it is hoped that health agencies, including hospitals, can apply the BSC concept.

As coronavirus disease 2019 (COVID-19) cases arose globally, active case finding by performing throat swab test proposed high risk for the healthcare workers. Saliva had recently been reported to show positive detection means for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and proposed advantages of self-collection, less requirement of transport media, and reduced nosocomial transmission risk. However, support evidence regarding its diagnostic value was still lacking and varied widely in specimen collection method. This systematic review aimed to assess the diagnostic value of salivary specimens (SS) for COVID-19 detection using reverse transcription polymerase chain reaction (RT-PCR) assay compared with throat swab specimens (TSS), while putting into consideration confounders such as patients’ initial condition, specimen collection method, and transport media used. Six databases were used for identifying relevant studies. Final search yielded 19 eligible studies which was reviewed based on the major outcome: diagnostic agreement, sensitivity & specificity, and viral load comparison. The use of SS as an alternative to TSS showed to be promising although specimen collection method needed to be standardized. SS was comparable to TSS in detecting COVID-19 using RT-PCR assay, especially in symptomatic or confirmed cases. More Randomized controlled trials (RCTs) were still needed to clearly demonstrate the ability of SS to capture asymptomatic cases in the setting of mass surveillance, where patients would self-collect the specimen at ease.